Pneumococcal Disease


PUBLISHED: 2008 CATEGORY: Health care providers TYPE: PDFPneumococcal vaccination and risk of myocardial infarction

Pneumococcal vaccination and risk of myocardial infarction

A hospital-based case-control study that included patients considered to be at risk of myocardial infarction. Health databases were used to obtain hospital diagnoses and vaccination status. Patients who had been admitted for myocardial infarction were compared to those admitted to a surgical department in the same hospital for a reason other than myocardial infarction betwen 1997 and 2003.

Authors: Lamontagne F et al.
Journal Issue: 8
Journal Title: Canadian Medical Association Journal
Journal Volume: 179
Publisher: Canadian Medical Association

PUBLISHED: 2007 CATEGORY: Health care providers TYPE: PDFInvasive pneumococcal infections in Canadian children, 1998-2003 : implications for new vaccination programs

Invasive pneumococcal infections in Canadian children, 1998-2003 : implications for new vaccination programs

Describes a study which conducted active surveillance for invasive pneumococcal disease to assess the serotype and antibiotic resistance patterns in Canada prior to universal infant immunization programs.

Authors: Bettinger J et al.
Journal Issue: 2
Journal Title: Canadian Journal of Public Health
Journal Volume: 98
Publisher: Canadian Public Health Association
Pubmed: 17441533

PUBLISHED: 2006 CATEGORY: Health care providers TYPE: PDFCanadian adult national immunization coverage (Adult NICS) survey 2006

Canadian adult national immunization coverage (Adult NICS) survey 2006

Provides a broad measure of coverage of six vaccinations (influenza, pneumococcal disease, hepatitis A and B, pertussis, varicella, and tetanus) among the adult Canadian population.

Corporate Authors: Environics Research Group
Publisher: Environics Research Group

PUBLISHED: 2004 CATEGORY: Health care providers TYPE: External Link Population-based impact of pneumococcal conjugate vaccine in young children

Population-based impact of pneumococcal conjugate vaccine in young children

Determines the population impact of pneumococcal conjugate vaccine on pneumococcal-related diseases.

Authors: Peohling K et al.
Journal Issue: 3
Journal Title: Pediatrics
Journal Volume: 114
Publisher: American Academy of Pediatrics
Pubmed: 15342850

PUBLISHED: 2003 CATEGORY: Health care providers TYPE: External Link Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine

Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine

Examined population-based data from the Active Bacterial Core Surveillance of the Centers for Disease Control and Prevention to evaluate changes in the burden of invasive disease.

Authors: Whitney CG et al.
Journal Issue: 18
Journal Title: New England Journal of Medicine
Journal Volume: 348
Publisher: Massachusetts Medical Society
Pubmed: 12724479

PUBLISHED: CATEGORY: Health care providers TYPE: External Link Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A CIRN Serious Outcomes Surveillance network study

Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A CIRN Serious Outcomes Surveillance network study

Authors: LeBlanc JJ et al.
Journal Issue: 29
Journal Title: Vaccine
Journal Volume: 35
Publisher: Elsevier